{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:51:44Z","timestamp":1786726304049,"version":"build-2736575974"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.yebeh.2019.106847","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T09:57:09Z","timestamp":1576663029000},"page":"106847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"PA","title":["Trazodone increases seizures in a genetic WAG\/Rij rat model of absence epilepsy while decreasing them in penicillin-evoked focal seizure model"],"prefix":"10.1016","volume":"103","author":[{"given":"Hatice","family":"Aygun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.yebeh.2019.106847_bb0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/14737175.2019.1585244","article-title":"Developments in depression in epilepsy: screening, diagnosis, and treatment","volume":"19","author":"Mula","year":"2019","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.yebeh.2019.106847_bb0010","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0140-6736(12)61455-X","article-title":"Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan","volume":"380","author":"Lin","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2019.106847_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.20685","article-title":"Depression and suicide attempt as risk factors for incident unprovoked seizures","volume":"59","author":"Hesdorffer","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2019.106847_bb0020","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.eplepsyres.2007.06.003","article-title":"Predictors of pharmacoresistant epilepsy","volume":"75","author":"Hitiris","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2019.106847_bb0025","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.0b013e3181f25b16","article-title":"Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients","volume":"75","author":"Petrovski","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.106847_bb0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/01.WNL.0000103282.62353.85","article-title":"Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy","volume":"62","author":"Boylan","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.106847_bb0035","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/bph.12052","article-title":"Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?","volume":"168","author":"Cardamone","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yebeh.2019.106847_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1528-1157.2002.043s2014.x","article-title":"Antidepressant drugs: indications and guidelines for use in epilepsy","volume":"43","author":"Schmitz","year":"2002","journal-title":"Epilepsia"},{"issue":"8 suppl 5","key":"10.1016\/j.yebeh.2019.106847_bb0045","first-page":"S27","article-title":"Depression and epilepsy: how closely related are they?","volume":"58","author":"Kanner","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.yebeh.2019.106847_bb0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.yebeh.2011.03.010","article-title":"The role of 5-HT(3) receptors in the additive anticonvulsant effects of citalopram and morphine on pentylenetetrazole-induced clonic seizures in mice","volume":"21","author":"Bahremand","year":"2011","journal-title":"Epilepsy Behav 2011"},{"issue":"1","key":"10.1016\/j.yebeh.2019.106847_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1254\/jphs.10156FP","article-title":"Serotonergic modulation of absence-like seizures in groggy rats: a novel rat model of absence epilepsy","volume":"114","author":"Ohno","year":"2010","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.yebeh.2019.106847_bb0060","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1471-4159.2006.04277.x","article-title":"Serotonin and epilepsy","volume":"100","author":"Bagdy","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2019.106847_bb0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports","volume":"62","author":"Alper","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2019.106847_bb0070","first-page":"617","article-title":"Adverse effects of antipsychotic medications","volume":"81","author":"Muench","year":"2010","journal-title":"Am Fam Physician"},{"issue":"2","key":"10.1016\/j.yebeh.2019.106847_bb0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","article-title":"Management of psychiatric and neurological comorbidities in epilepsy","volume":"12","author":"Kanner","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2019.106847_bb0080","first-page":"1","article-title":"The effect of duloxetine on penicillin-induced epileptiform activity in rats","volume":"41","author":"Esen","year":"2018","journal-title":"Neurol Res"},{"key":"10.1016\/j.yebeh.2019.106847_bb0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.yebeh.2019.03.050","article-title":"The effect of fluoxetine on penicillin-induced epileptiform activity","volume":"95","author":"Aygun","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2019.106847_bb0090","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jama.1987.03390040137034","article-title":"Tricyclic antidepressant overdose","volume":"257","author":"Frommer","year":"1987","journal-title":"A review JAMA"},{"issue":"4","key":"10.1016\/j.yebeh.2019.106847_bb0095","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S0100-879X2002000400010","article-title":"Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats","volume":"35","author":"Santos","year":"2002","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.yebeh.2019.106847_bb0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuint.2016.06.001","article-title":"Antidepressant drugs in convulsive seizures: pre-clinical evaluation of duloxetine in mice","volume":"99","author":"Santana-Coelho","year":"2016","journal-title":"Neurochem Int"},{"issue":"6","key":"10.1016\/j.yebeh.2019.106847_bb0105","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2174\/1871527315666160720121723","article-title":"Subacute fluoxetine reduces signs of hippocampal damage induced by a single convulsant dose of 4-aminopyridine in rats","volume":"16","author":"Shiha","year":"2017","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.yebeh.2019.106847_bb0110","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0033-3182(92)72008-8","article-title":"Fluoxetine-induced seizures","volume":"33","author":"Hargrave","year":"1992","journal-title":"Psychosomatics"},{"key":"10.1016\/j.yebeh.2019.106847_bb0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1192\/bjp.166.2.263a","article-title":"ECT seizure threshold and fluoxetine","volume":"166","author":"Tobiansky","year":"1995","journal-title":"Br J Psychiatry"},{"issue":"12","key":"10.1016\/j.yebeh.2019.106847_bb0120","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s40263-012-0010-5","article-title":"Rediscovering trazodone for the treatment of major depressive disorder","volume":"26","author":"Fagiolini","year":"2012","journal-title":"CNS Drugs"},{"issue":"23","key":"10.1016\/j.yebeh.2019.106847_bb0125","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.2174\/1381612821666150619092236","article-title":"Off-label trazodone prescription: evidence, benefits and risks","volume":"21","author":"Bossini","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.yebeh.2019.106847_bb0130","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/bmj.304.6828.686","article-title":"Hyponatraemia and seizure due to overdose of trazodone","volume":"304","author":"Balestrieri","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2019.106847_bb0135","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0735-6757(99)90104-3","article-title":"Seizure and hyponatraemia after overdose of trazodone","volume":"17","author":"Vanpee","year":"1999","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.yebeh.2019.106847_bb0140","series-title":"Drugs in psychiatric practice","first-page":"219","article-title":"New generation of antidepressants","author":"Barnes","year":"1982"},{"issue":"2","key":"10.1016\/j.yebeh.2019.106847_bb0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00002018-200225020-00004","article-title":"Effects of psychotropic drugs on seizure threshold","volume":"25","author":"Pisani","year":"2002","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.yebeh.2019.106847_bb0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0278-5846(90)90106-Q","article-title":"Immediate effects of 14 non MAOI antidepressants in rats with spontaneous petit mal-like seizures","volume":"14","author":"Warter","year":"1990","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2019.106847_bb0155","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0014-4886(68)90066-6","article-title":"The depolarization shift in \u2018epileptic\u2019 neurons","volume":"21","author":"Prince","year":"1968","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2019.106847_bb0160","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-0173(89)90003-9","article-title":"Animal models of the epilepsies","volume":"14","author":"Fisher","year":"1989","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.yebeh.2019.106847_bb0165","series-title":"In 2010 Annual International Conference of the IEEE Engineering in Medicine and Biology","first-page":"6674","article-title":"Automatic classification of penicillin-induced epileptic EEG spikes","author":"Kortelainen","year":"2010"},{"key":"10.1016\/j.yebeh.2019.106847_bb0170","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2147\/NDT.S50371","article-title":"Animal models of epilepsy: use and limitations","volume":"10","author":"Kandratavicius","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"10.1016\/j.yebeh.2019.106847_bb0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11910-017-0758-6","article-title":"The new classification of seizures by the International League Against Epilepsy 2017","volume":"7","author":"Fisher","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"10.1016\/j.yebeh.2019.106847_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1474-4422(03)00265-5","article-title":"Cellular biology of epileptogenesis","volume":"2","author":"Avanzini","year":"2003","journal-title":"Lancet Neurol"},{"issue":"Suppl. 12","key":"10.1016\/j.yebeh.2019.106847_bb0185","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.0013-9580.2003.12004.x","article-title":"Models and mechanisms of experimental epilepsies","volume":"44","author":"Jefferys","year":"2003","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2019.106847_bb0190","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.pnpbp.2010.11.010","article-title":"The WAG\/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression","volume":"35","author":"Sarkisova","year":"2011","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2019.106847_bb0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuropharm.2014.05.005","article-title":"Head-to head comparison of mGlu1 and mGlu5 receptor activation in chronic treatment of absence epilepsy in WAG\/Rij rats","volume":"85","author":"D'Amore","year":"2014","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.yebeh.2019.106847_bb0200","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.expneurol.2016.12.014","article-title":"Disinhibition of the intergeniculate leaflet network in the WAG\/Rij rat model of absence epilepsy","volume":"289","author":"Chrobok","year":"2017","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2019.106847_bb0205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000118147","article-title":"Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model","volume":"12","author":"Krijzer","year":"1984","journal-title":"Neuropsychobiol"},{"issue":"7","key":"10.1016\/j.yebeh.2019.106847_bb0210","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.euroneuro.2011.11.005","article-title":"Electrophysiological impact of trazodone on the dopamine and norepinephrine systems in the rat brain","volume":"22","author":"Ghanbari","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.yebeh.2019.106847_bb0215","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3906\/biy-1507-32","article-title":"The effects of agomelatine and melatonin on ECoG activity of absence epilepsy model in WAG\/Rij rats","volume":"39","author":"Aygun","year":"2015","journal-title":"Turk J Biol"},{"key":"10.1016\/j.yebeh.2019.106847_bb0220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbr.2019.01.060","article-title":"Swimming exercise decreases the absence-like epileptic activity in WAG\/Rij rats","volume":"363","author":"Aygun","year":"2019","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.yebeh.2019.106847_bb0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"04","key":"10.1016\/j.yebeh.2019.106847_bb0230","first-page":"121","article-title":"Epileptic seizures under antidepressive drug treatment: systematic review","volume":"1","author":"Steinert","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.yebeh.2019.106847_bb0235","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1192\/pb.19.6.355","article-title":"Which is the safest antidepressant to use in epilepsy?","volume":"19","author":"Duncan","year":"1995","journal-title":"Psychiatr Bull"},{"issue":"3","key":"10.1016\/j.yebeh.2019.106847_bb0240","first-page":"669","article-title":"Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome","volume":"140","author":"Griffin","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2019.106847_bb0245","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1176\/ajp.140.5.642b","article-title":"Seizure possibly caused by trazodone HCl","volume":"140","author":"Bowdan","year":"1983","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.yebeh.2019.106847_bb0250","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/archpsyc.1985.01790280105012","article-title":"Seizures and trazodone therapy","volume":"42","author":"Lefkowitz","year":"1985","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.yebeh.2019.106847_bb0255","first-page":"119","article-title":"Status epilepticus following electroconvulsive therapy","volume":"53","author":"Kaufman","year":"1986","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.yebeh.2019.106847_bb0260","first-page":"160","article-title":"Trazodone induced epilepsy","volume":"48","author":"Klein","year":"1993","journal-title":"Therapie"},{"key":"10.1016\/j.yebeh.2019.106847_bb0265","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1176\/ajp.150.3.525a","article-title":"Prolonged ECT seizure duration in a patient taking trazodone. Correspondence","volume":"150","author":"Lanes","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.yebeh.2019.106847_bb0270","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/j.1875-9114.1992.tb02665.x","article-title":"Antidepressants and the risk of seizures","volume":"12","author":"Skowron","year":"1992","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.yebeh.2019.106847_bb0275","first-page":"318","article-title":"Complex partial seizures in a patient receiving trazodone","volume":"47","author":"Tasini","year":"1986","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.yebeh.2019.106847_bb0280","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1734-1140(12)70910-6","article-title":"Trazodone reduces the anticonvulsant action of certain classical antiepileptics in the mouse maximal electroshock model","volume":"64","author":"Borowicz","year":"2012","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.yebeh.2019.106847_bb0285","first-page":"201","article-title":"Studies on the role of 5-HT2A and 5-HT2C receptor antagonist and effects of co-administration of Fluoxetines in regulating generalized seizures in albino rats","volume":"3","author":"Chavan","year":"2010","journal-title":"Al Ameen J Med Sci"},{"issue":"3","key":"10.1016\/j.yebeh.2019.106847_bb0290","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000026685","article-title":"Electrophysiologic analysis of antidepressant drug effects on the GABAA receptor complex based upon antagonist-induced encephalographic power spectrum changes","volume":"42","author":"Matsubara","year":"2000","journal-title":"Neuropsychobiol"},{"key":"10.1016\/j.yebeh.2019.106847_bb0295","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0028-3908(68)90069-5","article-title":"Pharmacological properties of AF 1161, a new psychotropic drug","volume":"7","author":"Silvestrini","year":"1968","journal-title":"Int J Neuropharmacol"},{"issue":"3","key":"10.1016\/j.yebeh.2019.106847_bb0300","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0304-3940(86)90586-0","article-title":"Two types of electrocortical paroxysms in an inbred strain of rats","volume":"70","author":"Van Luijtelaar","year":"1986","journal-title":"Neurosci Lett"},{"issue":"6","key":"10.1016\/j.yebeh.2019.106847_bb0305","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1023\/A:1026179013847","article-title":"Genetic animal models for absence epilepsy: a review of the WAG\/Rij strain of rats","volume":"33","author":"Coenen","year":"2003","journal-title":"Behav Genetics"},{"issue":"1","key":"10.1016\/j.yebeh.2019.106847_bb0310","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/00325481.2017.1249265","article-title":"A review of trazodone use in psychiatric and medical conditions","volume":"129","author":"Khouzam","year":"2017","journal-title":"Postgrad Med"},{"key":"10.1016\/j.yebeh.2019.106847_bb0315","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1528-1167.2009.02260.x","article-title":"Spike-wave discharges are necessary for the expression of behavioral depression-like symptoms","volume":"51","author":"Sarkisova","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106847_bb0320","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1111\/bph.13121","article-title":"Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behavior in the WAG\/Rij rat model of absence epilepsy","volume":"172","author":"Citraro","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yebeh.2019.106847_bb0325","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1046\/j.1528-1157.2002.48701.x","article-title":"Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy","volume":"43","author":"Hernandez","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106847_bb0330","doi-asserted-by":"crossref","first-page":"9271","DOI":"10.1523\/JNEUROSCI.2208-08.2008","article-title":"Serotonin hyperinnervation abolishes seizure susceptibility in Otx2 conditional mutant mice","volume":"28","author":"Tripathi","year":"2008","journal-title":"The J Neurosci"},{"issue":"1","key":"10.1016\/j.yebeh.2019.106847_bb0335","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.110.169417","article-title":"Sustained administration of trazodone enhances serotonergic neurotransmission: in vivo electrophysiological study in the rat brain","volume":"335","author":"Ghanbari","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.yebeh.2019.106847_bb0340","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(99)00644-5","article-title":"Trazodone increases extracellular serotonin levels in the frontal cortex of rats","volume":"383","author":"Pazzagli","year":"1999","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.yebeh.2019.106847_bb0345","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.bjp.0706935","article-title":"In vivo evidence that 5-HT2C receptors inhibit 5-HT neuronal activity via a GABAergic mechanism","volume":"149","author":"Boothman","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.yebeh.2019.106847_bb0350","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3233\/JAD-181106","article-title":"Treatment of Alzheimer's disease: trazodone, sleep, serotonin, norepinephrine, and future directions","volume":"67","author":"Ashford","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.yebeh.2019.106847_bb0355","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainresbull.2014.12.009","article-title":"Subacute administration of fluoxetine prevents short-term brain hypometabolism and reduces brain damage markers induced by the lithium-pilocarpine model of epilepsy in rats","volume":"111","author":"Shiha","year":"2015","journal-title":"Brain Res Bull 2015"},{"key":"10.1016\/j.yebeh.2019.106847_bb0360","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-4886(74)90126-5","article-title":"The effects of diphenylhydantoin, phenobarbital, and diazepam on the penicillin-induced epileptogenic focus in the rat","volume":"45","author":"Edmonds","year":"1974","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2019.106847_bb0365","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4149\/gpb_2017041","article-title":"Effect of the allopregnanolone and allotetrahydrodeoxycorticosteron on spike-wave discharges in the EEG of absence epilepsy rat models","volume":"37","author":"Karabulut","year":"2018","journal-title":"Gen Physiol Biophys"},{"issue":"1","key":"10.1016\/j.yebeh.2019.106847_bb0370","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2007.01.038","article-title":"Absence seizures are reduced by the enhancement of GABA-ergic inhibition in the hippocampus in WAG\/Rij rats","volume":"416","author":"Tolmacheva","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2019.106847_bb0375","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nm.2058","article-title":"Enhanced tonic GABAA inhibition in typical absence epilepsy","volume":"15","author":"Cope","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.yebeh.2019.106847_bb0380","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.mcn.2010.11.009","article-title":"Abnormalities in GABAergic synaptic transmission of intralaminar thalamic neurons in a genetic rat model of absence epilepsy","volume":"46","author":"Brockhaus","year":"2011","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"10.1016\/j.yebeh.2019.106847_bb0385","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neulet.2007.02.062","article-title":"5-HT2 modulation of AY-9944 induced atypical absence seizures","volume":"418","author":"Bercovici","year":"2007","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.yebeh.2019.106847_bb0390","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0014-4886(03)00352-2","article-title":"Bagdy G. 5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike\u2013wave discharges in a genetic rat model of absence epilepsy","volume":"184","author":"Jakus","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2019.106847_bb0395","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuropharm.2016.04.016","article-title":"Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures","volume":"108","author":"Venzi","year":"2016","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.yebeh.2019.106847_bb0400","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-8993(98)00801-4","article-title":"The 5-HT1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy","volume":"807","author":"Gerber","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2019.106847_bb0405","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0197-0186(00)00120-0","article-title":"8-OH-DPAT and MK- 801 affect epileptic activity independently of vigilance","volume":"38","author":"Filakovszky","year":"2001","journal-title":"Neurochem Int"},{"key":"10.1016\/j.yebeh.2019.106847_bb0410","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbr.2005.07.024","article-title":"Behavioral characteristics of WAG\/Rij rats susceptible and non-susceptible to audiogenic seizures","volume":"166","author":"Sarkisova","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.yebeh.2019.106847_bb0415","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0014-2999(86)90596-0","article-title":"Antagonism by antidepressants of serotonin S1 and S2 receptors of normal human brain in vitro","volume":"132","author":"Wander","year":"1986","journal-title":"Eur J Pharmacol"},{"issue":"13","key":"10.1016\/j.yebeh.2019.106847_bb0420","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0024-3205(02)01926-4","article-title":"Alterations in 5-HT1A receptors and adenylyl cyclase response by trazodone in regions of rat brain","volume":"71","author":"Subhash","year":"2002","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.yebeh.2019.106847_bb0425","first-page":"98","article-title":"Effect of selective serotonin reuptake inhibitor fluoxetine on symptoms of depression-like behavior in WAG\/Rij rats","volume":"60","author":"Sarkisova","year":"2010","journal-title":"Zh Vyssh Nerv Deiat Im I P Pavlova"},{"issue":"1","key":"10.1016\/j.yebeh.2019.106847_bb0430","first-page":"117","article-title":"Switching to fluoxetine in a case of sertraline-induced urinary incontinence: a case report","volume":"26","author":"\u00d6zdemir","year":"2013","journal-title":"Dusunen Adam"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019311424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019311424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:29:30Z","timestamp":1761503370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019311424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":86,"alternative-id":["S1525505019311424"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.106847","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trazodone increases seizures in a genetic WAG\/Rij rat model of absence epilepsy while decreasing them in penicillin-evoked focal seizure model","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.106847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106847"}}